These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23296384)

  • 21. Strategies for development of universal vaccines against meningococcal serogroup B disease: the most promising options and the challenges evaluating them.
    Holst J
    Hum Vaccin; 2007; 3(6):290-4. PubMed ID: 17712231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The PorB porin from commensal Neisseria lactamica induces Th1 and Th2 immune responses to ovalbumin in mice and is a potential immune adjuvant.
    Liu X; Wetzler LM; Massari P
    Vaccine; 2008 Feb; 26(6):786-96. PubMed ID: 18191311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune responses of a meningococcal A + W outer membrane vesicle (OMV) vaccine with and without aluminium hydroxide adjuvant in two different mouse strains.
    Tunheim G; Arnemo M; Naess LM; Norheim G; Garcia L; Cardoso D; Mandiarote A; Gonzalez D; Sinnadurai K; Fjeldheim ÅK; Bolstad K; Rosenqvist E
    APMIS; 2016 Nov; 124(11):996-1003. PubMed ID: 27651089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines.
    Sanders H; Feavers IM
    Expert Rev Vaccines; 2011 Mar; 10(3):323-34. PubMed ID: 21434800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neisseria lactamica protects against experimental meningococcal infection.
    Oliver KJ; Reddin KM; Bracegirdle P; Hudson MJ; Borrow R; Feavers IM; Robinson A; Cartwright K; Gorringe AR
    Infect Immun; 2002 Jul; 70(7):3621-6. PubMed ID: 12065503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical immunogenicity study of trivalent meningococcal AWX-OMV vaccines for the African meningitis belt.
    Tunheim G; Naess LM; Acevedo R; Fjeldheim ÅK; Bolstad K; García L; Cardoso D; Aase A; Zayas C; González H; Rosenqvist E; Norheim G
    Vaccine; 2014 Nov; 32(49):6631-8. PubMed ID: 25305564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity of various presentation forms of PorA outer membrane protein of Neisseria meningitidis in mice.
    Peeters CC; Claassen IJ; Schuller M; Kersten GF; van der Voort EM; Poolman JT
    Vaccine; 1999 Jun; 17(20-21):2702-12. PubMed ID: 10418921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine.
    Vermont CL; van Dijken HH; van Limpt CJ; de Groot R; van Alphen L; van Den Dobbelsteen GP
    Infect Immun; 2002 Feb; 70(2):584-90. PubMed ID: 11796586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Neisseria lactamica antigens putatively implicated in acquisition of natural immunity to Neisseria meningitidis.
    Troncoso G; Sánchez S; Criado MT; Ferreirós CM
    FEMS Immunol Med Microbiol; 2002 Sep; 34(1):9-15. PubMed ID: 12208601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid characterization of outer-membrane proteins in Neisseria lactamica by SELDI-TOF-MS (surface-enhanced laser desorption ionization-time-of-flight MS) for use in a meningococcal vaccine.
    Mukhopadhyay TK; Halliwell D; O'Dwyer C; Shamlou PA; Levy MS; Allison N; Gorringe A; Reddin KM
    Biotechnol Appl Biochem; 2005 Apr; 41(Pt 2):175-82. PubMed ID: 15315478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neisseria meningitidis serogroup C polysaccharide and serogroup B outer membrane vesicle conjugate as a bivalent meningococcus vaccine candidate.
    Fukasawa LO; Gorla MC; Schenkman RP; Garcia LR; Carneiro SM; Raw I; Tanizaki MM
    Vaccine; 1999 Aug; 17(23-24):2951-8. PubMed ID: 10462229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neisseria meningitidis, Neisseria lactamica and Moraxella catarrhalis share cross-reactive carbohydrate antigens.
    Braun JM; Beuth J; Blackwell CC; Giersen S; Higgins PG; Tzanakaki G; Unverhau H; Weir DM
    Vaccine; 2004 Feb; 22(7):898-908. PubMed ID: 15040943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870.
    Hou VC; Koeberling O; Welsch JA; Granoff DM
    J Infect Dis; 2005 Aug; 192(4):580-90. PubMed ID: 16028126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigen-specific T-cell responses in humans after intranasal immunization with a meningococcal serogroup B outer membrane vesicle vaccine.
    Oftung F; Naess LM; Wetzler LM; Korsvold GE; Aase A; Høiby EA; Dalseg R; Holst J; Michaelsen TE; Haneberg B
    Infect Immun; 1999 Feb; 67(2):921-7. PubMed ID: 9916109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Towards a nasal vaccine against meningococcal disease, and prospects for its use as a mucosal adjuvant.
    Haneberg B; Dalseg R; Oftung F; Wedege E; Høiby EA; Haugen IL; Holst J; Andersen SR; Aase A; Meyer Naess L; Michaelsen TE; Namork E; Haaheim LR
    Dev Biol Stand; 1998; 92():127-33. PubMed ID: 9554266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae.
    Leduc I; Connolly KL; Begum A; Underwood K; Darnell S; Shafer WM; Balthazar JT; Macintyre AN; Sempowski GD; Duncan JA; Little MB; Rahman N; Garges EC; Jerse AE
    PLoS Pathog; 2020 Dec; 16(12):e1008602. PubMed ID: 33290434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological Effects of Dimethyldioctadecylammonium Bromide and Saponin as Adjuvants for Outer Membrane Vesicles from
    Correa VA; Portilho AI; De Gaspari E
    Diseases; 2022 Jul; 10(3):. PubMed ID: 35892740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of mucosal immunity in the human upper respiratory tract to the commensal bacteria Neisseria lactamica but not pathogenic Neisseria meningitidis during the peak age of nasopharyngeal carriage.
    Vaughan AT; Gorringe A; Davenport V; Williams NA; Heyderman RS
    J Immunol; 2009 Feb; 182(4):2231-40. PubMed ID: 19201877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of IgG and IgM to meningococcal outer membrane proteins in relation to carriage of Neisseria meningitidis or Neisseria lactamica.
    Kremastinou J; Tzanakaki G; Pagalis A; Theodondou M; Weir DM; Blackwell CC
    FEMS Immunol Med Microbiol; 1999 May; 24(1):73-8. PubMed ID: 10340715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine.
    Marjuki H; Topaz N; Joseph SJ; Gernert KM; Kersh EN; ; Wang X
    mBio; 2019 Sep; 10(5):. PubMed ID: 31506309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.